logo conference-reports

Conference Reports

An educational program funded by logo MSD Oncology

BLOOD 2019 – Detection of CD274 (PD-L1) and PDCD1LG2 (PD-L2) abnormalities in cellular and circulating tumour DNA in lymphoid malignancy – a highly clinically relevant target

Next-generation sequencing clinches the therapy when uncertainty exists